Delay in caffeine elimination in breast-fed infants

Area of Science:

• Neonatal Medicine
• Pharmacology
• Biochemistry

Background:

• Persistent elevated caffeine half-life in breastfed infants during therapy necessitates further investigation.
• Caffeine metabolism maturation in infants is crucial for drug safety.

Purpose of the Study:

• To compare caffeine elimination and half-life in exclusively breast-fed versus formula-fed infants.
• To investigate the role of human milk components in infant caffeine metabolism.

Main Methods:

• Prospective longitudinal study comparing two groups of infants (5 breast-fed, 12 formula-fed).
• Measurement of caffeine half-life, elimination rates, and blood levels at various postconceptional ages.

Main Results:

• Breast-fed infants exhibited significantly delayed caffeine elimination and longer half-lives (e.g., 76 +/- 13 hours vs. 21 +/- 28 hours).
• Higher blood caffeine levels (3-5 fold) were observed in breast-fed infants after 46 weeks' postconceptional age.
• One breast-fed infant showed extreme caffeine accumulation with a half-life increasing from 102 to 372 hours.

Conclusions:

• Components in human milk, such as free fatty acids or lipase activity, may inhibit the maturation of infant caffeine metabolism via hepatic cytochrome P-450.
• This inhibition can lead to elevated caffeine levels and potential accumulation in breast-fed infants.
• Findings suggest a parallel with breast milk jaundice, indicating a need for careful caffeine therapy monitoring in this population.